27 Sep 22
ONWARD Reports First Half 2022 Financial and Operating Results
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland & BOSTON, MA USA — September 27, 2022, 7:30 CET– ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its first half 2022 financial and operating results.
26 Sep 22
ONWARD Announces Appointment of Vivian Riefberg to Board of Directors
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—September 26, 2022—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
21 Sep 22
ONWARD to Release Half Year 2022 Financial Results and Host Webcast on September 27, 2022
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—September 21, 2022—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish the half year 2022 financial and operating results on Tuesday, September 27, 2022.
13 Sep 22
ONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People with Spinal Cord Injury

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, USA—September 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that the Up-LIFT pivotal study evaluating ARC-EX Therapy achieved its primary effectiveness

Upcoming Events

Recent Presentations